Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Shuhang Wang"'
Publikováno v:
Environmental Science and Pollution Research. 30:64363-64376
Autor:
Shuhang Wang, Peiwen Ma, Ning Jiang, Yale Jiang, Yue Yu, Yuan Fang, Huilei Miao, Huiyao Huang, Qiyu Tang, Dandan Cui, Hong Fang, Huishan Zhang, Qi Fan, Yuning Wang, Gang Liu, Zicheng Yu, Qi Lei, Ning Li
Publikováno v:
Frontiers of Medicine. 17:220-230
Autor:
Ning Jiang, Yue Yu, Dawei Wu, Shuhang Wang, Yuan Fang, Huilei Miao, Peiwen Ma, Huiyao Huang, Min Zhang, Yu Zhang, Yu Tang, Ning Li
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 149:737-747
Publikováno v:
npj Vaccines. 8
Unfair older patients restriction in cancer drug trials in mainland China and corresponding solution
Autor:
Huiyao Huang, Yu Tang, Dawei Wu, Xinyu Meng, Shuhang Wang, Jun Wang, Yue Yu, Yuan Fang, Hong Fang, Qi Zhu, Ning Li, Binghe Xu, Yan Sun, Jie He
Publikováno v:
BMC Geriatrics. 23
Background Older adults are a growing segment of oncology population in China and beyong. However, older cancer patients were vastly underrepresented in clinical trial. To facilitate that all patients with cancer have equal access to the cutting edgi
Publikováno v:
Frontiers of Environmental Science & Engineering. 17
Autor:
Zhijie Wang, Ning Li, Fengwei Tan, Shuhang Wang, Ning Wu, Changyuan Guo, Jie He, Jiacong Wei, Yun Ling, Shugeng Gao, Jianming Ying, Pei Yuan, Jie Wang, Lin Li, Xiuli Tao
Publikováno v:
NPJ Precision Oncology
Neoadjuvant immunotherapy provides a unique opportunity for understanding therapeutic responses. We analyzed pathologic responses in surgical specimens obtained from 31 squamous non-small cell lung cancer (NSCLC) patients receiving neoadjuvant anti-P
Publikováno v:
Machine Vision and Applications. 29:1127-1142
Visual context is fundamental to understand human actions in videos. However, the discriminative temporal information of videos is usually sparse and most frames are redundant mixed with a large amount of interference information, which may result in
Publikováno v:
Frontiers of Medicine. 10:383-388
The tyrosine kinase inhibitors (TKI) of the epidermal growth factor receptor (EGFR) are becoming the first line of therapy for advanced non-small cell lung cancer (NSCLC). Acquired mutations in EGFR account for one of the major mechanisms of resistan
Publikováno v:
Journal of Hematology & Oncology
Journal of Hematology & Oncology, Vol 10, Iss 1, Pp 1-6 (2017)
Journal of Hematology & Oncology, Vol 10, Iss 1, Pp 1-6 (2017)
Programmed death ligand 1 (PD-L1) has emerged as a biomarker that can help to predict responses to immunotherapies targeted against PD-L1 and its receptor (PD-1). Companion tests for evaluating PD-L1 expression as a biomarker of response have been de